| Filed On | Filing |
|---|---|
| 10 Nov 2026 |
Form 4: Rossitto Erica, SVP & Chief Nurse Executive
Received 13,120 shares by exercise or conversion ($1.17M) · Gave up 6,601 shares to cover exercise price or tax ($3.27M) · Sold 3,500 shares ($1.77M) |
| 10 Nov 2026 | 144 |
| 06 Nov 2026 |
Form 4: Elcan Patricia F, 10% owner
Disposed of 886,871 shares (Other Transaction) ($447M) · Acquired 886,871 shares (Other Transaction) ($447M) |
| 06 Nov 2026 |
Form 4: Frist Thomas F Iii, Director
Disposed of 555,500 shares (Other Transaction) ($280M) · Acquired 555,500 shares (Other Transaction) ($280M) |
| 06 Nov 2026 | SCHEDULE 13D/A |
| 06 Nov 2026 |
Form 4: Schlosser Michael J, EVP and Chief Clinical Officer
Sold 1,200 shares ($594K) |
| 06 Nov 2026 |
Form 4: Foster Jon M, EVP and COO
Sold 10,000 shares ($5.14M) · Received 35,880 shares by exercise or conversion ($5.21M) · Gave up 20,309 shares to cover exercise price or tax ($10.4M) · 2 more |
| 05 Nov 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
andDEUTSCHE BANK TRUST COMPANY AMERICAS,as Paying Agent, Registrar and Transfer Agent |
| 04 Nov 2026 | 144 |
| 04 Nov 2026 | 144 |
| 04 Nov 2026 | 424B5 |
| 03 Nov 2026 |
Form 4: Marks Mike A, EVP and CFO
Received 4,585 shares by exercise or conversion ($376K) · Gave up 2,287 shares to cover exercise price or tax ($1.08M) · Disposed of 1,042 shares (Other Transaction) ($489K) · 1 more |
| 03 Nov 2026 | FWP |
| 02 Nov 2026 |
Form 4: Schlosser Michael J, EVP and Chief Clinical Officer
Received 4,928 shares by exercise or conversion ($406K) · Gave up 2,455 shares to cover exercise price or tax ($1.17M) · Granted 2,797 Stock Appreciation Right |
| 02 Nov 2026 |
8-K: Other Events
NASHVILLE, Tenn., November 2, 2026 – HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior note... |
| 02 Nov 2026 | 424B3 |
| 29 Oct 2026 | 10-Q |
| 29 Oct 2026 | 144 |
| 27 Oct 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
Nashville, Tenn., October 27, 2026 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2026. |
| 11 Sep 2026 |
Form 3: Schlosser Michael J, EVP and Chief Clinical Officer
Holds 170.1027 shares of Common Stock |
Loading...